Verona Pharma (VRNA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Verona Pharma

    NASDAQ: VRNA · Real-Time Price · USD
    106.79
    -0.03 (-0.03%)
    At close: Oct 03, 2025, 3:59 PM
    106.90
    0.10%
    After-hours: Oct 03, 2025, 06:10 PM EDT

    Verona Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 399.76M 271.77M 227.83M 148.38M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 15M 15M 15M 15M
    Other Long-Term Assets
    		 1.97M n/a 15.07M 15.08M
    Receivables
    		 37.26M 10.95M 9.28M 15.58M
    Inventory
    		 6.25M n/a 2.5M 4.04M
    Other Current Assets
    		 2.73M 3.37M 3.39M 2.06M
    Total Current Assets
    		 453.57M 289.71M 243M 170.06M
    Property-Plant & Equipment
    		 3.15M 2.87M 927K 979K
    Goodwill & Intangibles
    		 545K 545K 545K 545K
    Total Long-Term Assets
    		 20.67M 18.42M 16.47M 16.52M
    Total Assets
    		 474.24M 308.12M 259.47M 186.59M
    Account Payables
    		 11.27M 3.49M 2.91M 10.04M
    Deferred Revenue
    		 n/a n/a n/a 22.4M
    Short-Term Debt
    		 1.12M n/a n/a n/a
    Other Current Liabilities
    		 2.43M 435K 1.41M 327K
    Total Current Liabilities
    		 42.68M 8.69M 19.03M 33.42M
    Long-Term Debt
    		 120.34M 48.37M 9.77M 4.87M
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 227M 50.15M 9.97M 5.16M
    Total Liabilities
    		 269.68M 58.84M 29M 38.58M
    Total Debt
    		 122.7M 51.33M 10.65M 5.81M
    Book Value
    		 204.56M 249.28M 230.47M 148M
    Book Value Per Share
    		 2.51 3.30 3.49 2.50
    Common Stock
    		 43.36M 42.77M 40.53M 31.86M
    Retained Earnings
    		 -562.4M -388.43M -333.1M -263.72M
    Comprehensive Income
    		 -4.6M -4.6M -4.6M -4.6M
    Shareholders Equity
    		 204.56M 249.28M 230.47M 148M
    Total Investments
    		 15M 15M 15M 15M

    Add to Watchlist